Use of Mefenamic Acid Premedication Prior to CO 2 Laser Treatment to the Cervix

Allan MacLean, ENID HAMILTON, David Peddie
In: Journal of Gynecologic Surgery · 1986 · vol. 2(1) , pp. 31–34 · doi:10.1089/gyn.1986.2.31 · W1994162086
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Mefenamic acid 750 mg or placebo was taken, double-blind, by patients 2 hours before CO2 laser treatment of cervical premalignant lesions. During and after treatment each patient was assessed as to the type and severity of sensation experienced. Mefenamic acid did not prevent the dysmenorrhea-like symptom experienced by many patients undergoing such treatment.

My notes (saved in your browser only)

Condition tags

dysmenorrhea

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (8)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-13T06:45:44.122212+00:00
License: CC0 · commercial use OK